CYTK (STOCKS)
Cytokinetics Inc.
$66.130000
+1.120000 (+1.72%)
Prev close: $65.010000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Robert I. Blum
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $8,213.74M
- Employees
- 498
- P/E (TTM)
- -10.21
- P/B (TTM)
- -12.44
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $88.04M |
| Benefits Costs and Expenses | $872.99M |
| Costs And Expenses | $872.99M |
| Nonoperating Income/Loss | $48.42M |
| Operating Expenses | $700.30M |
| Research and Development | $416.03M |
| Other Operating Expenses | $284.27M |
| Operating Income/Loss | -$612.26M |
| Income/Loss From Continuing Operations After Tax | -$784.96M |
| Income/Loss From Continuing Operations Before Tax | -$784.96M |
| Income Tax Expense/Benefit | $0.00 |
| Interest Expense, Operating | $45.58M |
| Net Income/Loss | -$784.96M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$784.96M |
| Net Income/Loss Available To Common Stockholders, Basic | -$784.96M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$6.54 |
| Diluted Earnings Per Share | -$6.54 |
| Basic Average Shares | 120,103 |
| Diluted Average Shares | 120,103 |
| Assets | $1.42B |
| Current Assets | $916.98M |
| Cash | $1.20B |
| Noncurrent Assets | $507.56M |
| Fixed Assets | $79.19M |
| Other Non-current Assets | $428.37M |
| Liabilities | $2.08B |
| Current Liabilities | $202.45M |
| Accounts Payable | $22.34M |
| Wages | $45.15M |
| Other Current Liabilities | $134.97M |
| Noncurrent Liabilities | $1.88B |
| Equity | -$659.63M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$659.63M |
| Liabilities And Equity | $1.42B |
| Net Cash Flow From Operating Activities | -$510.01M |
| Net Cash Flow From Operating Activities, Continuing | -$510.01M |
| Net Cash Flow From Investing Activities | $16.67M |
| Net Cash Flow From Investing Activities, Continuing | $16.67M |
| Net Cash Flow From Financing Activities | $524.46M |
| Net Cash Flow From Financing Activities, Continuing | $524.46M |
| Exchange Gains/Losses | -$715.00K |
| Net Cash Flow | $30.40M |
| Net Cash Flow, Continuing | $31.12M |
| Comprehensive Income/Loss | -$786.72M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$786.72M |
| Other Comprehensive Income/Loss | -$1.77M |